DermTech Inc (NAS:DMTK)
$ 0.638 0.018 (2.9%) Market Cap: 22.31 Mil Enterprise Value: 20.21 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 44/100

DermTech Inc at ICR Virtual Conference Transcript

Jan 14, 2021 / 03:00PM GMT
Release Date Price: $39.67 (+1.41%)
Caroline Corner

Welcome, and thank you for joining us. I'm Caroline Corner, Managing Director at Westwicke ICR in medical technology practice. We've all had or know someone who's had a mole removed during a skin cancer scare, and many of us have the scars to prove it. The client DermTech is using their smart sticker technology, which is pressed onto a suspicious mole to remove skin's genetic material to test for melanoma.

Today, I'm here with DermTech's Chief Financial Officer, Kevin Sun; who earlier this month completed a $125 million equity financing to fuel their launch and pipeline plans. Kevin, welcome, and I'll turn it over to you.

Kevin Sun
DermTech, Inc. - CFO, Treasurer & Secretary

Great. Thank you, Caroline, and thank you, everyone, for joining us today to learn a little bit about our company.

First, our standard disclaimer language. We usually like to start talking about our company with our leadership team. We've got a tremendous leadership team here. John Dobak, our CEO, has been with us the longest. He is an entrepreneur at heart

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot